A post-mortem and a look at what’s next
Recapping a year of buyout rumors
1
An exciting approach to auto-immune conditions published in Science shows the broad potential of future mRNA therapies
2
Our world in charts
3
Use these to help make $XBI a better place
8
1
 
1
Drugging the undruggable, not redrugging the druggable
4
COVID-19 Variant & Flu POCT and the New Normal
1
8,500 words on $TRIL $ALXO $IMAB $STTK $OSE $GILD
2
Looking at portfolio changes for RA, Perceptive, Baker, OrbiMed, BVF, EcoR1, Redmile, Opaleye, Ghost Tree
3
2,700 words
2
1,500 words
1